Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
DLL3 inhibitor
DRUG CLASS:
DLL3 inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
BI 764532 (5)
tarlatamab-dlle (4)
PT217 (1)
MK-6070 (0)
QLS31904 (0)
RG6524 (0)
ZG006 (0)
BI 764532 (5)
tarlatamab-dlle (4)
PT217 (1)
MK-6070 (0)
QLS31904 (0)
RG6524 (0)
ZG006 (0)
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Small Cell Lung Cancer
No biomarker
Small Cell Lung Cancer
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
DLL3 expression
Neuroendocrine Tumor
DLL3 expression
Neuroendocrine Tumor
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
BI 764532
Sensitive: B - Late Trials
BI 764532
Sensitive
:
B
No biomarker
Small Cell Lung Cancer
No biomarker
Small Cell Lung Cancer
tarlatamab-dlle
Sensitive: B - Late Trials
tarlatamab-dlle
Sensitive
:
B
tarlatamab-dlle
Sensitive: B - Late Trials
tarlatamab-dlle
Sensitive
:
B
No biomarker
Small Cell Lung Cancer
No biomarker
Small Cell Lung Cancer
PT217
Sensitive: B - Late Trials
PT217
Sensitive
:
B
PT217
Sensitive: B - Late Trials
PT217
Sensitive
:
B
DLL3 expression
Small Cell Lung Cancer
DLL3 expression
Small Cell Lung Cancer
tarlatamab-dlle
Sensitive: C3 – Early Trials
tarlatamab-dlle
Sensitive
:
C3
tarlatamab-dlle
Sensitive: C3 – Early Trials
tarlatamab-dlle
Sensitive
:
C3
DLL3 positive
Non Small Cell Lung Cancer
DLL3 positive
Non Small Cell Lung Cancer
tarlatamab-dlle
Sensitive: C3 – Early Trials
tarlatamab-dlle
Sensitive
:
C3
tarlatamab-dlle
Sensitive: C3 – Early Trials
tarlatamab-dlle
Sensitive
:
C3
DLL3 positive
Small Cell Lung Cancer
DLL3 positive
Small Cell Lung Cancer
BI 764532
Sensitive: C3 – Early Trials
BI 764532
Sensitive
:
C3
BI 764532
Sensitive: C3 – Early Trials
BI 764532
Sensitive
:
C3
DLL3 positive
Neuroendocrine Tumor
DLL3 positive
Neuroendocrine Tumor
BI 764532
Sensitive: C3 – Early Trials
BI 764532
Sensitive
:
C3
BI 764532
Sensitive: C3 – Early Trials
BI 764532
Sensitive
:
C3
DLL3 underexpression
Small Cell Lung Cancer
DLL3 underexpression
Small Cell Lung Cancer
tarlatamab-dlle
Sensitive: D – Preclinical
tarlatamab-dlle
Sensitive
:
D
tarlatamab-dlle
Sensitive: D – Preclinical
tarlatamab-dlle
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login